HROW · NASDAQ · Drug Manufacturers - Specialty & Generic

Harrow (HROW)

Commercializes branded eye medicines and ImprimisRx compounding for US ophthalmology.

$33.86
vs last close−0.59 (−1.71%)
  1. Harrow: Now Is The Buy Time

    Seeking Alpha